Log in
Enquire now

List of Sandoz patents

List of Sandoz patents
List of InterCall patents
List of BHP patents
List of Lifetime Brands patents
List of AI building material companies
List of companies in Nautilus Venture Partners's investment portfolio
Patents where
Current Assignee
Name
is
SandozSandoz
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9149439 Multi-particulate, modified-release composition

Patent 9149439 was granted and assigned to Sandoz on October, 2015 by the United States Patent and Trademark Office.

Sandoz
Sandoz
United States Patent and Trademark Office
United States Patent and Trademark Office
9149439
October 6, 2015
‌
US Patent 9938239 Method for preparing silodosin

Patent 9938239 was granted and assigned to Sandoz on April, 2018 by the United States Patent and Trademark Office.

Sandoz
Sandoz
United States Patent and Trademark Office
United States Patent and Trademark Office
9938239
April 10, 2018
‌
US Patent 9387233 Long-term storage of non-glycosylated recombinant human G-CSF

Patent 9387233 was granted and assigned to Sandoz on July, 2016 by the United States Patent and Trademark Office.

Sandoz
Sandoz
United States Patent and Trademark Office
United States Patent and Trademark Office
9387233
July 12, 2016
‌
US Patent 10030010 Route of synthesis for the preparation of suvorexant

Patent 10030010 was granted and assigned to Sandoz on July, 2018 by the United States Patent and Trademark Office.

Sandoz
Sandoz
United States Patent and Trademark Office
United States Patent and Trademark Office
10030010
July 24, 2018
‌
US Patent 9815879 Method for the purification of G-CSF

Patent 9815879 was granted and assigned to Sandoz on November, 2017 by the United States Patent and Trademark Office.

Sandoz
Sandoz
United States Patent and Trademark Office
United States Patent and Trademark Office
9815879
November 14, 2017
‌
US Patent 9499504 Crystalline form of vortioxetine hydrobromide

Patent 9499504 was granted and assigned to Sandoz on November, 2016 by the United States Patent and Trademark Office.

Sandoz
Sandoz
United States Patent and Trademark Office
United States Patent and Trademark Office
9499504
November 22, 2016
‌
US Patent 10206880 Solid dispersion comprising an orexin receptor antagonist

Patent 10206880 was granted and assigned to Sandoz on February, 2019 by the United States Patent and Trademark Office.

Sandoz
Sandoz
United States Patent and Trademark Office
United States Patent and Trademark Office
10206880
February 19, 2019
‌
US Patent 10159661 Penicillin retard composition for intramuscular injection

Patent 10159661 was granted and assigned to Sandoz on December, 2018 by the United States Patent and Trademark Office.

Sandoz
Sandoz
United States Patent and Trademark Office
United States Patent and Trademark Office
10159661
December 25, 2018
‌
US Patent 9254261 Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid

Patent 9254261 was granted and assigned to Sandoz on February, 2016 by the United States Patent and Trademark Office.

Sandoz
Sandoz
United States Patent and Trademark Office
United States Patent and Trademark Office
9254261
February 9, 2016
‌
US Patent 10160779 Synthesis of phosphoramidates

Patent 10160779 was granted and assigned to Sandoz on December, 2018 by the United States Patent and Trademark Office.

Sandoz
Sandoz
United States Patent and Trademark Office
United States Patent and Trademark Office
10160779
December 25, 2018
‌
US Patent 11124513 Avibactam free acid

Patent 11124513 was granted and assigned to Sandoz on September, 2021 by the United States Patent and Trademark Office.

Sandoz
Sandoz
Sandoz
Sandoz
United States Patent and Trademark Office
United States Patent and Trademark Office
11124513
September 21, 2021
‌
US Patent D1042795 Drug delivery device

Patent D1042795 was granted and assigned to Sandoz on September, 2024 by the United States Patent and Trademark Office.

Sandoz
Sandoz
Sandoz
Sandoz
United States Patent and Trademark Office
United States Patent and Trademark Office
D1042795
September 17, 2024
‌
US Patent 11970450 Multi-component crystals of an orally available HIF prolyl hydroxylase inhibitor

Patent 11970450 was granted and assigned to Sandoz on April, 2024 by the United States Patent and Trademark Office.

Sandoz
Sandoz
Sandoz
Sandoz
United States Patent and Trademark Office
United States Patent and Trademark Office
11970450
April 30, 2024
‌
US Patent D1029237 Drug delivery device

Patent D1029237 was granted and assigned to Sandoz on May, 2024 by the United States Patent and Trademark Office.

Sandoz
Sandoz
Sandoz
Sandoz
United States Patent and Trademark Office
United States Patent and Trademark Office
D1029237
May 28, 2024
14 results
0 selected
14 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us